It is becoming increasingly clear that the autonomic nervous system and the immune system demonstrate cross-talk during inflammation by means of sympathetic and parasympathetic pathways 1,2 . We investigated whether phagocytes are capable of de novo production of catecholamines, suggesting an autocrine/paracrine self-regulatory mechanism by catecholamines during inflammation, as has been described for lymphocytes 3 . Here we show that exposure of phagocytes to lipopolysaccharide led to a release of catecholamines and an induction of catecholamine-generating and degrading enzymes, indicating the presence of the complete intracellular machinery for the generation, release and inactivation of catecholamines. To assess the importance of these findings in vivo, we chose two models of acute lung injury. Blockade of a 2 -adrenoreceptors or catecholamine-generating enzymes greatly suppressed lung inflammation, whereas the opposite was the case either for an a 2 -adrenoreceptor agonist or for inhibition of catecholamine-degrading enzymes. We were able to exclude T cells or sympathetic nerve endings as sources of the injury-modulating catecholamines. Our studies identify phagocytes as a new source of catecholamines, which enhance the inflammatory response.
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Although tumor, rubor, dolor and calor (the Latin terms for swelling, redness, pain and heat) are classical features of acute inflammation, the proximal trigger of these responses is neuronal in origin. Similarly, the systemic acute-phase response to infection involves neurone-dependent responses (fever and activation of the hormonal stress response), which are regulated mainly by the hypothalamus 2 . Innate immunity and inflammation are the first lines of defence 4 , with initial responses involving non-specific cellular and humoral pathways, resulting in mediator release 1 . Immune and proinflammatory mediators that are subsequently released rapidly activate neuronal responses that amplify local immune and inflammatory responses designed to contain pathogens and trigger systemic neuroendocrine and regional neural responses that seek to return the system to a homeostatic state 2 . One of the key pathways involved in the neuroendocrine-immune modulating network is the autonomic nervous system. Recently, vagal parasympathetic signalling has been shown to have an important regulatory function in inflammation through cholinergic receptors on phagocytic cells 1, 5, 6 . Functional interplay of the adrenergic nervous system with the immune/inflammatory system may counterbalance effects of the parasympathetic nervous system. The presence and synthesis of catecholamines in lymphocytes were first described more than a decade ago 3, 7 . Catecholamines can thereby modulate the proliferation, differentiation and apoptosis of lymphocytes and the production of cytokines through adrenoreceptors expressed on T and B cells [8] [9] [10] [11] [12] . To investigate whether macrophages and neutrophils (polymorphonuclear cells; PMNs) might be able to generate and release catecholamines, as has been suggested 13, 14 , cells were incubated with bacterial lipopolysaccharide (LPS) and levels of noradrenaline and adrenaline in cell supernatants were determined. As shown in Fig. 1a -d, noradrenaline and adrenaline levels increased significantly in cell supernatants 15 min after exposure of macrophages and PMNs to LPS, decreasing at 1 h and 2 h, and then increasing by 4 h. Experiments were repeated with human PMNs exposed to the potent complement anaphylatoxin C5a (10 nM), with virtually identical results (data not shown). On the basis of these findings, we conducted experiments to evaluate the presence of two key enzymes involved in catecholamine synthesis in macrophages and PMNs after stimulation with LPS. Tyrosine hydroxylase (TH) is known to be the rate-limiting step in catecholamine synthesis, whereas dopamine b-hydroxylase (DBH) accounts for the final step of noradrenaline synthesis, converting dopamine to noradrenaline 15 . Macrophages or blood PMNs were incubated for 15 min and 4 h with 30 ng ml 21 LPS. Thereafter, messenger RNA expression for catecholamine-generating enzymes was analysed by real-time polymerase chain reaction (PCR). Low baseline mRNA levels for both key enzymes (TH and DBH) were detected in unstimulated macrophages. At 4 h after cell exposure to LPS, mRNAs for both enzymes were significantly upregulated (Fig. 1e,  f) . PMNs expressed low constitutive levels of mRNA for TH and DBH, but both were clearly upregulated 4 h after the addition of LPS (Fig. 1g, h ). The actions of catecholamines can be terminated in three ways: by reuptake into nerve terminals, by diffusion into extracellular fluids or by metabolic transformation. Two enzymes are essential in the metabolic inactivation of catecholamines: monoamine oxidase (MAO) and catechol O-methyltransferase (COMT). Unstimulated macrophages contained mRNA for both COMT and MAO-A (Fig. 2a, b) . After exposure of cells to LPS, the quantity of mRNA for COMT decreased whereas that for MAO-A increased. In accordance with this, when proteins were analysed by western blotting, exposure to LPS caused a decrease in macrophage COMT (Fig. 2c) , whereas the same intervention brought about higher levels of MAO-A protein (Fig. 2d) . Similar patterns were found in PMNs. Incubation with LPS decreased the level of mRNA for COMT (Fig. 2e ) and increased that of mRNA for MAO-A (Fig. 2f) . COMT protein amounts decreased when PMNs were exposed to LPS (Fig. 2g) ; the opposite was true for MAO-A (Fig. 2h) . During COMT-mediated O-methylation of catecholamines, S-adenosylmethionine (SAM) serves as the methyl donor and is subsequently converted to S-adenosyl-L-homocysteine (SAH) after donation of the methyl group to the substrate. It has been known for many years that elevated SAH levels can serve as a strong inhibitor of the COMT-mediated O-methylation metabolism of catechols 16, 17 . Increased phagocyte production of catecholamines might therefore lead to an increased turnover of COMT, increasing levels of the powerful feedback inhibitor SAH and ultimately causing the downregulation of cellular mRNA and protein levels of COMT (Fig. 2) . Collectively, these data indicate that LPS-stimulated macrophages and PMNs express catecholamine-generating and degrading enzymes and release noradrenaline and adrenaline after exposure to LPS in vitro. Thus, phagocytes possess the complete cellular machinery to generate catecholamines de novo and to release and inactivate them.
To evaluate the relevance of these findings in vivo, we used two different models of acute lung injury (induced by LPS and by IgG immune complex) to study the effects of adrenoceptor blockade in the setting of a single-organ injury. Adrenoceptors were blocked in vivo by using the appropriate antagonists in the two different models of lung inflammatory injury (Fig. 3a, c) . The antagonists were delivered intraperitoneally. Vascular leakage of albumin into lungs, which correlates with lung injury, was measured after the deposition of IgG immune complexes (IC) or LPS in the lung. a 1 -Adrenoceptors were blocked by prazosin, whereas a 2 -adrenoceptors were blocked with RX 821002. b 1 -Adrenoceptors were blocked by metoprolol, and b 2 -adrenoceptor blockade was induced by ICI 118551. Only blockade of the a 2 -adrenoceptors significantly reduced the intensity of the albumin leak into lung in the two models of injury, whereas blockade of other receptors neither intensified nor reduced the level of lung injury (Fig. 3a, c) . Blockade of the b 2 -adrenoceptors with different doses of ICI 118551 (10-20 mg kg 21 ) failed to alter injury intensity significantly (data not shown). To clarify the significance of the a 2 -adrenoceptors in our models of lung injury, an a 2 -adrenergic agonist (UK 14304) was used to assess effects on lung injury. As shown in Fig. 3b, d , the severity of lung damage increased twofold and fourfold, respectively, when induction of IgG or LPS lung injury was followed immediately by intraperitoneal administration of UK 14304, whereas the a 2 -adrenoceptor inhibitor RX 821002 substantially suppressed lung injury in each of the two models. The effects of these interventions were consistent with the morphological evaluation of lungs ( Fig. 3e-k) . Although the levels of lung injury with LPS and IC (positive controls) were comparable (Fig. 3f , i, respectively), animals treated with UK 14304 showed clearly increased evidence of injury as reflected in increased PMN numbers, fibrin and haemorrhage in the interstitial and alveolar compartments (Fig. 3g, j) . In sharp contrast, blockade of the a 2 -adrenoceptor by RX 821002 reduced the intensity of inflammation and injury (Fig. 4h, k a 2 -adrenoceptor in these models of lung injury. a 2 -Adrenoceptors belong to the G-protein-coupled, seven-transmembrane receptor family 18 and are currently divided into three subtypes: a 2A , a 2B and a 2C (ref. 19) . In the present study we found that both alveolar macrophages and blood PMNs express all three subtypes of the a 2 -adrenoceptors ( Supplementary Fig. 1 ).
To exclude T cells or the sympathetic nerve endings as sources of the injury-modulating catecholamines, we achieved T-cell depletion with an antibody and sympathetic denervation by administering reserpine. Recovery of sympathetic function after administration of reserpine takes up to several weeks 20 . In the present study we harvested and exposed PMNs and alveolar macrophages to LPS 4 days after administration of reserpine in vivo to determine whether the production of catecholamines by phagocytes is impaired by reserpine. There was no difference in noradrenaline production between phagocytes from control and reserpine-treated animals (Fig. 4a) . Accordingly, we induced lung injury in the presence or absence of a 2 -adrenoceptor blockade in control animals and animals treated 4 days earlier with reserpine. Injury levels were significantly increased in reserpine-treated animals, whereas a 2 -adrenoceptor blockade completely abolished vascular leakage (Fig. 4c) . We repeated these experiments in vitro and in vivo 2 h after reserpine administration, with identical results (data not shown). As expected, adrenal gland homogenates from reserpine-treated animals had almost no detectable noradrenaline (Fig. 4b) . In parallel experiments, mice were depleted of CD4 T cells and the intensity of albumin leakage was assessed. There was no change in the level of injury between T-cell-depleted and isotype-control-treated littermates. In the same animals, a 2 -adrenoceptor blockade was protective (Fig. 4d) . Bronchoalveolar lavage (BAL) fluid analysis was performed to determine whether the sympathetic nervous system and T cells were key sources of catecholamines in current models of lung injury. Peak levels of adrenaline occurred in BAL fluids 2 h after the initiation of immune-complex-mediated injury (Fig. 4e) . In parallel, an adrenaline peak was found 3 h after the initiation of LPS-induced lung injury (data not shown). Other mice were depleted of PMNs, alveolar macrophages or T cells or were pharmacologically sympathectomized and subjected to lung injury. BAL fluids were obtained and measured 2 h after the initiation of injury. Whereas depletion of PMNs and alveolar macrophages significantly decreased the presence of adrenaline in BAL fluids, reserpine-induced sympathectomy did not decrease adrenaline levels (Fig. 4f) . These data indicate that the presence of adrenaline in BAL fluids requires PMNs and macrophages but not T cells. Phagocytes of adrenalectomized animals have higher baseline levels of TH, DBH and catecholamine secretion (M.A.F., D.R., R.P.L., A.J.C., D.E.D., B.A.N., F.S.Z., J.V.S., A. B. Lentsch, M.S.H.-L. and P.A.W., unpublished observations). It might be possible that the baseline production of catecholamines in phagocytes is increased as a compensatory endogenous mechanism to pharmacological sympathectomy. Last, we showed that pharmacological blockade of the catecholamine-generating TH (by using a-methyltyrosine) and DBH (by using fusaric acid) greatly diminished the inflammatory response, whereas inhibition of the catecholamine-degrading enzymes COMT (with dinitrocatechol) and MAO (with moclobemide) significantly increased lung injury as defined by the permeability index (Fig. 4g) .
Alveolar macrophages and PMNs have a central function in the pathophysiology of IgG IC-induced lung injury 21 . The a 2 -adrenoreceptor is expressed on alveolar macrophages 11 , and modulation of the a 2 -adrenoceptor regulates LPS-induced production of tumour necrosis factor (TNF)-a in vitro from alveolar macrophages 22 . We sought to determine whether in vitro blockade of the adrenoceptors, especially the a 2 -adrenoreceptor, might be linked to the present findings in vivo. There was a variable inhibition in vitro of various macrophage-derived cytokines (TNF-a, interleukin-6 and interleukin-1b) and chemokines (cytokine-induced neutrophil chemoattractant (CINC)-1) by a 1 -adrenoceptor, a 2 -adrenoceptor, b 1 -adrenoceptor or b 2 -adrenoceptor blockade (Supplementary  Table 1) , with blockade of the a 2 -adrenoreceptor achieving the most consistent suppression of mediators. Identical experiments with PMNs revealed similar patterns (data not shown).
Taken together, the results of this study indicate that both alveolar macrophages and blood PMNs are capable of the production of catecholamines de novo and of their release, implicating phagocytes as a previously unrecognized source of catecholamines. Enhanced production or decreased generation of catecholamines (with the use of inhibitors of catecholamine-generating or catecholaminedegrading enzymes) increases or decreases the intensity of inflammatory injury, respectively. Blockade of a 2 -adrenoceptors in vivo greatly decreases the intensity of inflammatory injury. In many respects, the phagocytic system can be looked on as a diffusely expressed adrenergic organ.
METHODS SUMMARY
Animals and anaesthesia. All studies were conducted in accordance with the University of Michigan Committee on Use and Care of Animals. Specific pathogen-free male Long-Evans rats (300-325 g; Taconic) or C57BL/6 mice (Jackson Laboratory) were anaesthetized with isoflurane (Aerrane; Henry Schein). Isolation of PMNs and alveolar macrophages. Whole blood was drawn into syringes containing anticoagulant citrate dextrose (ACD) (Baxter Health Care), in a volume ratio of 1:10. Neutrophils were isolated by using Ficoll-Paque gradient centrifugation (Pharmacia Biotech AB) followed by a dextran sedimentation step. After hypotonic lysis of residual red blood cells, neutrophils were resuspended in Hanks balanced salt solution (HBSS) containing Ca 21 and Mg 21 . Rat alveolar macrophages were isolated by repeatedly lavaging the lungs of anaesthetized healthy animals. After centrifugation of BAL fluids, cells were resuspended in HBSS containing Ca 21 and Mg 21 . Stimulation of phagocytes by LPS. 
